We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Shape Memory Medical Stock

Invest in or calculate the value of your shares in Shape Memory Medical or other pre-IPO companies through EquityZen's platform.

Get Started

Shape Memory Medical Stock (SHMM)

Shape Memory Medical is a medical device company that develops innovative medical devices based on Shape Memory Polymer (SMP) materials.

About Shape Memory Medical Stock

Founded

2009

Headquarters

Santa Clara, CA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Shape Memory Medical Inc is a medical device company based in Santa Clara, California, founded to commercialize innovative medical devices based on Shape Memory Polymer (SMP) materials that were developed at Texas A&M University and Lawrence Livermore National Laboratory. The company is dedicated to developing innovative therapeutic solutions for peripheral vascular, cardiovascular, and neurovascular markets. Shape Memory Medical's device is the first to introduce an FDA-cleared medical device utilizing shape memory polymer (SMP) technology to a vascular market, enabling physicians to improve patient care. The Shape Memory Medical team has extensive experience with the SMP foam technology and the commercialization of medical devices.

Shape Memory Medical Management

Leadership team at Shape Memory Medical

Board Member

Thom Rasche

President & CEO

Edward (Ted) Ruppel, Jr.

Locked Features

Join now and verify your accreditation status to gain access to:

  • Shape Memory Medical current valuation
  • Shape Memory Medical stock price
  • Available deals in Shape Memory Medical and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Shape Memory Medical Stock

How to invest in Shape Memory Medical stock?

Accredited investors can buy pre-IPO stock in companies like Shape Memory Medical through EquityZen funds. These investments are made available by existing Shape Memory Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Shape Memory Medical stock?

Shareholders can sell their Shape Memory Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."